M
20
-4
DVN
16
3
MRK
22
3
AVGO
20
-5
NWL
44
-4
ACN
47
-2
QCOM
48
-7
EIX
77
2
RSG
68
3
MAS
51
4
NAVI
41
-3
EXC
54
-2
STI
47
-12
UHS
54
3
AMGN
44
5
DHI
48
3
IBM
54
4
SYK
64
-4
HSIC
54
-3
LH
42
2
M
20
-4
DVN
16
3
MRK
22
3
AVGO
20
-5
NWL
44
-4
ACN
47
-2
QCOM
48
-7
EIX
77
2
RSG
68
3
MAS
51
4
NAVI
41
-3
EXC
54
-2
STI
47
-12
UHS
54
3
AMGN
44
5
DHI
48
3
IBM
54
4
SYK
64
-4
HSIC
54
-3
LH
42
2
Financhill
Back

Arbutus Biopharma Vs. Amicus Therapeutics Industry Stock Comparison

Sell
36

ABUS
Arbutus Biopharma

Last Price:
3.46
Seasonality Move:
15.21%
Sell
25

FOLD
Amicus Therapeutics

Last Price:
9.49
Seasonality Move:
7.75%
Sell
36
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.44. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.59. The Score for FOLD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 28.99 Sell
Chaikin Money Flow: -417405 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.64 - 4.06) Sell
Bollinger Bands (100): (3.55 - 4.13) Sell

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 29.32 Sell
Chaikin Money Flow: 783674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.22 - 11.78) Sell
Bollinger Bands (100): (10.18 - 11.54) Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.59 Sell
20-day SMA: 3.79 Sell
50-day SMA: 3.93 Sell
200-day SMA: 3.37 Buy
8-day EMA: 3.59 Sell
20-day EMA: 3.73 Sell
50-day EMA: 3.83 Sell
200-day EMA: 3.43 Buy

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.01 Sell
20-day SMA: 10.86 Sell
50-day SMA: 10.88 Sell
200-day SMA: 11.01 Sell
8-day EMA: 10 Sell
20-day EMA: 10.52 Sell
50-day EMA: 10.8 Sell
200-day EMA: 11.03 Sell

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):